Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Product sales, net	$ 2,248,845	$ 2,597,598
Cost of products sold	572,742	708,135
Gross profit	1,676,103	1,889,463
Selling, general and administrative expenses	3,035,276	3,074,572
Research and development expenses	94,211	140,347
Depreciation and amortization expense	11,684	17,220
Total operating expenses	3,141,171	3,232,139
Loss from operations	(1,465,068)	(1,342,676)
Interest income (expense)	(3,351)	23,345
Unrealized Gain Treasury investment	27,890	0
Loss before provision for income taxes	(1,440,529)	(1,319,331)
Provision for income taxes	0	0
Net loss	(1,440,529)	(1,319,331)
Net loss attributable to noncontrolling interests	0	(11,665)
Net loss attributable to Milestone Scientific Inc.	$ (1,440,529)	$ (1,307,666)
Net loss per share applicable to common stockholders—
Basic and Diluted (in dollars per share)	$ (0.02)	$ (0.02)
Weighted average shares outstanding and to be issued—
Basic and Diluted (in shares)	79,738,551	72,104,234